Vineel Muppidi1, Lingaiah Jadi2, Kalicheti Prabhakar Reddy3, Sudeep Madisetti 4, Anvesh Krishna Medi5, Madasani Anunya Reddy6
BACKGROUND
The eye is especially susceptible to the symptoms of allergic rhinitis, itching (pruritus), tearing (epiphora) and redness (erythema) because it lacks a mechanical barrier that could prevent the deposition of allergens, such as pollen on the conjunctival surface. These ocular symptoms have been described as examples of the type 1 immediate hypersensitivity reaction. A number of recently published clinical studies apparently support the positive effect of intranasal steroidal sprays on ocular allergy symptoms.
The aim of the study is to evaluate the role of intranasal steroids in relieving ocular symptoms in allergic rhinitis.
MATERIALS AND METHODS
60 subjects who had seasonal allergic rhinitis with ocular symptoms came to Outpatient Department of Chalmeda Anand Rao Hospital in the year 2015-2016. Randomly, each intranasal steroid is given to 12 patients to a total of 60 patients for 4 weeks 2 puffs in each nostril twice daily and the clinical response is observed.
RESULTS
A subjective improvement in ocular symptoms was observed in 11 of the 12 patients treated with fluticasone furoate, 8 of 12 patients with fluticasone propionate, 7 of the 12 patients with mometasone furoate, 6 of the 12 patients with beclomethasone and 6 of the 12 patients with budesonide.
CONCLUSION
Intranasal corticosteroids, which are used for seasonal allergic rhinitis with ocular symptoms are effective in controlling of ocular symptoms. Among these, intranasal corticosteroids, which are used for allergic rhinitis, fluticasone furoate is more effective in relieving ocular symptoms in our study.
